Injection of the histone deacetylases inhibitor trichostatin A to rats has been shown to decrease the reinforcing properties of cocaine. In the present study, we investigated alterations in gene expression patterns in the anterior cingulate cortex, caudate-putamen and nucleus accumbens of rats self-administering cocaine and treated with trichostatin A. As recent studies highlighted the importance of chromatin remodelling in the regulation of gene transcription in neurons, we studied the expression of Mecp2 and of several histone deacetylases. Cocaine self-administration was accompanied by an increased synthesis of Mecp2, HDAC2 and HDAC11 and by a decreased nuclear localization of HDAC5 and of the phospho-form of HDAC5, suggesting a nuclear export of this protein in response to the drug. The latter mechanism was further addressed by the demonstration of an enhanced expression of MEF2C transcription factor. Among the genes we examined, treatment with trichostatin A before each cocaine self-administration session was found to mostly affect Mecp2 and HDAC11 expression. A correlation was found between the modification of Mecp2 and MEF2C gene expression and the reinforcing property of cocaine. The two factors known to regulate gene transcription are likely to play a role in the neurobiological mechanism underlying a decrease in the reinforcing properties of cocaine.
AjamianFSalminenAReebenM. (2004) Selective regulation of class I and class II histone deacetylases expression by inhibitors of histone deacetylases in cultured mouse neural cells. Neurosci Lett365: 64–68.
BroideRSRedwineJMAftahiNYoungWBloomFEWinrowCJ. (2007) Distribution of histone deacetylases 1–11 in the rat brain. J Mol Neurosci31: 47–58.
4.
CaineSBLintzRKoobGF. (1993) Intravenous drug self-administration techniques in animals. In: SahgalA (ed.) Behavioural neuroscience: a practical approach. Oxford: Oxford University Press, 117–143.
5.
CasselSRevelMOKelcheCZwillerJ. (2004) Expression of the methyl-CpG-binding protein MeCP2 in rat brain. An ontogenetic study. Neurobiol Dis15: 206–211.
6.
CasselSCarougeDGensburgerC. (2006) Fluoxetine and cocaine induce the epigenetic factors MeCP2 and MBD1 in adult rat brain. Mol Pharmacol70: 487–492.
7.
ChomczynskiPSacchiN. (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate–phenol–chloroform extraction. Anal Biochem162: 156–159.
8.
de RuijterAJvan GennipAHCaronHNKempSvan KuilenburgAB. (2003) Histone deacetylases (HDACs): characterization of the classical HDAC family. Biochem J370: 737–749.
9.
Di ChiaraGImperatoA. (1988) Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc Natl Acad Sci USA85: 5274–5278.
10.
GaoLCuetoMAAsselbergsFAtadjaP. (2002) Cloning and functional characterization of HDAC11, a novel member of the human histone deacetylase family. J Biol Chem277: 25748–25755.
11.
GhoshalKDattaJMajumderS. (2002) Inhibitors of histone deacetylase and DNA methyltransferase synergistically activate the methylated metallothionein I promoter by activating the transcription factor MTF-1 and forming an open chromatin structure. Mol Cell Biol22: 8302–8319.
12.
HaberlandMMontgomeryRLOlsonEN. (2009) The many roles of histone deacetylases in development and physiology: implications for disease and therapy. Nat Rev Genet10: 32–42.
HocklyERichonVMWoodmanB. (2003) Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor, ameliorates motor deficits in a mouse model of Huntington’s disease. Proc Natl Acad Sci USA100: 2041–2046.
15.
HubbertCGuardiolaAShaoR. (2002) HDAC6 is a microtubule-associated deacetylase. Nature417: 455–458.
16.
JenuweinTAllisCD. (2001) Translating the histone code. Science293: 1074–1080.
17.
KimBRincon CastroLMJawedSNilesLP. (2008) Clinically relevant concentrations of valproic acid modulate melatonin MT(1) receptor, HDAC and MeCP2 mRNA expression in C6 glioma cells. Eur J Pharmacol589: 45–48.
18.
KouzaridesT. (2007) Chromatin modifications and their function. Cell128: 693–705.
19.
LeSageMGStaffordDGlowaJR. (1999) Preclinical research on cocaine self-administration: environmental determinants and their interaction with pharmacological treatment. Neurosci Biobehav Rev23: 717–741.
20.
LevineAAGuanZBarcoAXuSKandelERSchwartzJH. (2005) CREB-binding protein controls response to cocaine by acetylating histones at the fosB promoter in the mouse striatum. Proc Natl Acad Sci USA102: 19186–19191.
21.
Lopez-RodasGBroschGGeorgievaEISendraRFrancoLLoidlP. (1993) Histone deacetylase. A key enzyme for the binding of regulatory proteins to chromatin. FEBS Lett317: 175–180.
22.
MarushigeK. (1976) Activation of chromatin by acetylation of histone side chains. Proc Natl Acad Sci USA73: 3937–3941.
23.
McKinseyTAZhangCLOlsonEN. (2000) Activation of the myocyte enhancer factor-2 transcription factor by calcium/calmodulin-dependent protein kinase-stimulated binding of 14–3-3 to histone deacetylase 5. Proc Natl Acad Sci USA97: 14400–14405.
24.
NanXNgHHJohnsonCA. (1998) Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex. Nature393: 386–389.
RobertsDCSCorcoranMEFobigerHC. (1977) On the role of ascending catecholaminergic systems in intravenous self-administration of cocaine. Pharmacol Biochem Behav6: 615–620.
28.
RomieuPHostLGobailleSSandnerGAunisDZwillerJ. (2008) Histone deacetylase inhibitors decrease cocaine but not sucrose self-administration in rats. J Neurosci28: 9342–9348.
29.
RothSYDenuJMAllisCD. (2001) Histone acetyltransferases. Annu Rev Biochem70: 81–120.
30.
SchroederFALinCLCrusioWEAkbarianS. (2007) Antidepressant-like effects of the histone deacetylase inhibitor, sodium butyrate, in the mouse. Biol Psychiatry62: 55–64.
31.
VerdinEDequiedtFKaslerHG. (2003) Class II histone deacetylases: versatile regulators. Trends Genet19: 286–293.
32.
WalkinshawDRTahmasebiSBertosNRYangXJ. (2008) Histone deacetylases as transducers and targets of nuclear signaling. J Cell Biochem104: 1541–1552.
33.
WangDZValdezMRMcAnallyJRichardsonJOlsonEN. (2001) The Mef2c gene is a direct transcriptional target of myogenic bHLH and MEF2 proteins during skeletal muscle development. Development128: 4623–4633.
34.
WhiteFJKalivasPW. (1998) Neuroadaptations involved in amphetamine and cocaine addiction. Drug Alcohol Depend51: 141–153.
35.
XiongYDowdySCPodratzKC. (2005) Histone deacetylase inhibitors decrease DNA methyltransferase-3B messenger RNA stability and down-regulate de novo DNA methyltransferase activity in human endometrial cells. Cancer Res65: 2684–2689.
36.
YangXJSetoE. (2008) The Rpd3/Hda1 family of lysine deacetylases: from bacteria and yeast to mice and men. Nat Rev Mol Cell Biol9: 206–218.
